DRUG-RESISTANT TUBERCULOSIS AND COMORBID DIABETES MELLITUS: IMPROVEMENT OF HEALTHCARE PROVISION
Effectiveness of medical care for patients with drug-resistant tuberculosis and comorbid diabetes mellitus (DM) was studied using modern approaches to monitoring DM compensation, including continuous glucose monitoring, and tuberculosis treatment: use of new and repurposed antituberculosis drugs; consideration of pathogen drug resistance and interaction of all pharmaceuticals received by the patient; careful monitoring and correction of adverse events, which allowed to continue chemotherapy successfully (without interruption in treatment) and avoid decompensation of DM, achieve high efficiency of underlying disease treatment according to criterion of “abacillation” (89,0%).